Qualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration.

TitleQualitatively different T cell phenotypic responses to IL-2 versus IL-15 are unified by identical dependences on receptor signal strength and duration.
Publication TypeJournal Article
Year of Publication2014
AuthorsArneja, A, Johnson, H, Gabrovsek, L, Lauffenburger, DA, White, FM
JournalJ Immunol
Volume192
Issue1
Pagination123-35
Date Published2014 Jan 1
ISSN1550-6606
KeywordsCell Line, Cell Proliferation, Cluster Analysis, Humans, Interleukin-15, Interleukin-2, Lymphocyte Activation, Phenotype, Phosphorylation, Receptors, Cytokine, Receptors, Interleukin-12, Receptors, Interleukin-2, Signal Transduction, T-Lymphocytes, Tyrosine
Abstract

IL-2 and IL-15 are common γ-chain family cytokines involved in regulation of T cell differentiation and homeostasis. Despite signaling through the same receptors, IL-2 and IL-15 have non-redundant roles in T cell biology, both physiologically and at the cellular level. The mechanisms by which IL-2 and IL-15 trigger distinct phenotypes in T cells remain elusive. To elucidate these mechanisms, we performed a quantitative comparison of the phosphotyrosine signaling network and resulting phenotypes triggered by IL-2 and IL-15. This study revealed that the signaling networks activated by IL-2 or IL-15 are highly similar and that T cell proliferation and metabolism are controlled in a quantitatively distinct manner through IL-2/15R signal strength independent of the cytokine identity. Distinct phenotypes associated with IL-2 or IL-15 stimulation therefore arise through differential regulation of IL-2/15R signal strength and duration because of differences in cytokine-receptor binding affinity, receptor expression levels, physiological cytokine levels, and cytokine-receptor intracellular trafficking kinetics. These results provide important insights into the function of other shared cytokine and growth factor receptors, quantitative regulation of cell proliferation and metabolism through signal transduction, and improved design of cytokine based clinical immunomodulatory therapies for cancer and infectious diseases.

DOI10.4049/jimmunol.1302291
Alternate JournalJ. Immunol.
PubMed ID24298013
PubMed Central IDPMC3950894
Grant ListR01 AI065824 / AI / NIAID NIH HHS / United States
R01 AI065824 / AI / NIAID NIH HHS / United States
U54 CA112967 / CA / NCI NIH HHS / United States
U54CA11927 / CA / NCI NIH HHS / United States